Get a Quote

ingredient science · · 6 min read

Berberine: Market Momentum, Sourcing, and Formulation Considerations

For B2B ingredient evaluation only. This article summarizes published research and market context for formulation and sourcing decisions; it is not a consumer health, disease prevention or treatment claim. Confirm the regulatory status of any ingredient and claim in your target market before use.

How a traditional alkaloid became one of the most-watched raw materials in the global supplement supply chain.

A botanical alkaloid long used in Chinese herbal medicine has become one of the most-discussed raw materials in the international supplement industry. In 2023, US natural-channel demand rose sharply: natural-channel sales nearly doubled, up 98.3% to almost $8.4 million, and SPINS data showed roughly $4.2 million of additional consumer spending in a single year, lifting berberine from 29th to 15th place in the channel.

According to Business Research Insights, the global berberine market is estimated at about $1.4 billion in 2026 and projected to reach $3.52 billion by 2035, a compound annual growth rate (CAGR) of 11.25% over the forecast period.

For ingredient buyers and formulators, the useful question is not the consumer narrative but the supply-side picture: where berberine comes from, what makes it technically demanding to formulate, and how its regulatory status differs across markets.

Botanical Source and Composition

Berberine is an isoquinoline alkaloid found primarily in Coptis chinensis (Huang Lian) and Phellodendron amurense (Huang Bo). For B2B supply it is most commonly offered as berberine hydrochloride, characterized by assay (purity) and standardized to a declared berberine content, with batch documentation (COA, TDS, MSDS) supporting each lot.

A Heavily Studied Alkaloid

Berberine is among the more extensively studied botanical alkaloids in the published literature. Research has examined its activity on the AMPK energy-sensing pathway and its interaction with the gut microbiota. One frequently noted property is its very low oral bioavailability, with research exploring how it acts substantially within the gastrointestinal tract rather than entering the bloodstream.

This information describes the published research record and the material's technical properties. GreeneryBio supplies berberine as a raw material for B2B formulation and manufacturing and makes no health, disease, or treatment claims; the content here is provided for ingredient evaluation only.

Bioavailability: The Core Formulation Challenge

Berberine's low oral absorption is the central technical consideration for product developers. Common formulation approaches include nano-encapsulation, phospholipid complexes, and combination with other compounds to address absorption. A credible, well-documented bioavailability approach is a key differentiator in finished-product development.

The Global Market: Who Is Buying

North America is the single largest consumption region, accounting for roughly 20% of global berberine supplement sales. Mainstream supplement brands — including Now Foods, Solaray, and Thorne — market berberine products, predominantly in capsule form, with doses commonly in the 500–1000 mg range. Brand competition centers on three pillars: purity, third-party testing, and formulations that address bioavailability.

China: A Different Regulatory Picture

Berberine's position in its native market is the opposite of its overseas momentum. As an active constituent of Coptis chinensis and related herbs, berberine in China is largely confined to the pharmaceutical category. This restricts its use in food and health-food applications, since berberine not approved for those uses cannot be added to such products domestically — a contrast with the more open North American environment. Any future approval as a novel food ingredient, or addition to the health-food raw-material catalog, would change that picture, but the regulatory path is demanding.

What This Means for Buyers

For B2B buyers, three points matter:

  1. Sourcing and specification. Confirm botanical source, assay/standardization, and third-party testing; request a COA and TDS for each batch.
  2. Bioavailability strategy. Evaluate how a finished-product partner addresses berberine's low absorption.
  3. Market-specific regulation. Permitted use differs between China and overseas markets; confirm the regulatory status for your target market before committing volume.

GreeneryBio supplies berberine HCl with batch documentation (COA, TDS, MSDS available on request). For specification, pricing, or samples, contact our team.


Reference

Zamani M, Zarei M, et al. Berberine: A review of its pharmacokinetics properties and therapeutic potentials in diverse vascular diseases. Frontiers in Nutrition, 2022, 9: 1013055.